0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine Software Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-31Z9803
Home | Market Reports
Global Nuclear Medicine Software Market Insights Forecast to 2028
BUY CHAPTERS

Global Nuclear Medicine Software Market Research Report 2026

Code: QYRE-Auto-31Z9803
Report
2026-01-19
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Medicine Software Market Size

The global Nuclear Medicine Software market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 173 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

Nuclear Medicine Software Market

Nuclear Medicine Software Market

Nuclear Medicine Software is a computer program system specifically designed for the entire workflow of nuclear medicine imaging, encompassing every stage from patient management and image acquisition to reconstruction, processing, analysis, and report generation. Its core task is to process the signals of radioactive tracer distribution within the body, captured by devices such as gamma cameras, SPECT, or PET scanners, and convert them into diagnostic anatomical-functional fusion images using specialized algorithms. This software not only provides quantitative analysis tools but also deeply integrates artificial intelligence technology to enhance image quality and assist in lesion detection and segmentation. As an intelligent hub connecting imaging equipment, hospital information systems, and clinical decision-making, nuclear medicine software is a key technological platform for improving diagnostic accuracy, optimizing workflows, and supporting cutting-edge research.
The costs of Nuclear Medicine Software primarily include substantial research and development investments (algorithm development, clinical validation), ongoing regulatory certification fees, and customer customization and technical support costs. Its gross profit margin is typically very high, reaching 70%-85% for standard products. This is mainly because its core value lies in intellectual property and software licenses; once developed, the marginal cost of replication is extremely low. The revenue model is primarily based on software licensing fees, annual maintenance fees, and fees charged per analysis module.
The current Nuclear Medicine Software market is undergoing a period of rapid growth and transformation driven by technological advancements. With the increasing adoption of PET/CT and PET/MR technologies and the emergence of new radiopharmaceuticals, the market is experiencing a surge in demand for precise quantitative analysis and multimodal fusion, driving the evolution of software from basic imaging tools to intelligent diagnostic platforms. The deep integration of artificial intelligence is a core trend, significantly improving image reconstruction quality and the efficiency and accuracy of automatic lesion detection and quantitative analysis. The market is dominated by international giants, but cloud-based SaaS models and third-party AI software companies are introducing new dimensions of competition. Simultaneously, driven by the development of precision medicine and integrated diagnosis and treatment, software applications are expanding into areas such as radiotherapy planning, neuroscience, and new drug development. Regulatory compliance and data security requirements are also becoming increasingly stringent, resulting in a market characterized by high added value and high technological barriers.
This report delivers a comprehensive overview of the global Nuclear Medicine Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nuclear Medicine Software. The Nuclear Medicine Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nuclear Medicine Software market comprehensively. Regional market sizes by Type, by Application, by Deployment, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nuclear Medicine Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Nuclear Medicine Software Market Report

Report Metric Details
Report Name Nuclear Medicine Software Market
Accounted market size in 2025 US$ 118 million
Forecasted market size in 2032 US$ 173 million
CAGR 5.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Drug Management
  • Radiation Management
  • Other
Segment by Deployment
  • On Premise Software
  • Cloud-Based Software
Segment by Function
  • Image Acquisition and Reconstruction Software
  • Image Processing and Analysis Software
  • Reporting and Information Management Software
  • Others
Segment by Application
  • Clinical Diagnosis
  • Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus, Mirion Medical, PAIRE, GE HealthCare, Inter Medical, Sirona
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Deployment, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Nuclear Medicine Software companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Nuclear Medicine Software Market growing?

Ans: The Nuclear Medicine Software Market witnessing a CAGR of 5.6% during the forecast period 2026-2032.

What is the Nuclear Medicine Software Market size in 2032?

Ans: The Nuclear Medicine Software Market size in 2032 will be US$ 173 million.

Who are the main players in the Nuclear Medicine Software Market report?

Ans: The main players in the Nuclear Medicine Software Market are iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus, Mirion Medical, PAIRE, GE HealthCare, Inter Medical, Sirona

What are the Application segmentation covered in the Nuclear Medicine Software Market report?

Ans: The Applications covered in the Nuclear Medicine Software Market report are Clinical Diagnosis, Research, Others

What are the Type segmentation covered in the Nuclear Medicine Software Market report?

Ans: The Types covered in the Nuclear Medicine Software Market report are Drug Management, Radiation Management, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drug Management
1.2.3 Radiation Management
1.2.4 Other
1.3 Market by Deployment
1.3.1 Global Nuclear Medicine Software Market Size Growth Rate by Deployment: 2021 vs 2025 vs 2032
1.3.2 On Premise Software
1.3.3 Cloud-Based Software
1.4 Market by Function
1.4.1 Global Nuclear Medicine Software Market Size Growth Rate by Function: 2021 vs 2025 vs 2032
1.4.2 Image Acquisition and Reconstruction Software
1.4.3 Image Processing and Analysis Software
1.4.4 Reporting and Information Management Software
1.4.5 Others
1.5 Market by Application
1.5.1 Global Nuclear Medicine Software Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Clinical Diagnosis
1.5.3 Research
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Software Market Perspective (2021–2032)
2.2 Global Nuclear Medicine Software Growth Trends by Region
2.2.1 Global Nuclear Medicine Software Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Nuclear Medicine Software Historic Market Size by Region (2021–2026)
2.2.3 Nuclear Medicine Software Forecasted Market Size by Region (2027–2032)
2.3 Nuclear Medicine Software Market Dynamics
2.3.1 Nuclear Medicine Software Industry Trends
2.3.2 Nuclear Medicine Software Market Drivers
2.3.3 Nuclear Medicine Software Market Challenges
2.3.4 Nuclear Medicine Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Software Players by Revenue
3.1.1 Global Top Nuclear Medicine Software Players by Revenue (2021–2026)
3.1.2 Global Nuclear Medicine Software Revenue Market Share by Players (2021–2026)
3.2 Global Top Nuclear Medicine Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Software Revenue
3.4 Global Nuclear Medicine Software Market Concentration Ratio
3.4.1 Global Nuclear Medicine Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Software Revenue in 2025
3.5 Global Key Players of Nuclear Medicine Software Head Offices and Areas Served
3.6 Global Key Players of Nuclear Medicine Software, Products and Applications
3.7 Global Key Players of Nuclear Medicine Software, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Nuclear Medicine Software Breakdown Data by Type
4.1 Global Nuclear Medicine Software Historic Market Size by Type (2021–2026)
4.2 Global Nuclear Medicine Software Forecasted Market Size by Type (2027–2032)
5 Nuclear Medicine Software Breakdown Data by Application
5.1 Global Nuclear Medicine Software Historic Market Size by Application (2021–2026)
5.2 Global Nuclear Medicine Software Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Nuclear Medicine Software Market Size (2021–2032)
6.2 North America Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Nuclear Medicine Software Market Size by Country (2021–2026)
6.4 North America Nuclear Medicine Software Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Software Market Size (2021–2032)
7.2 Europe Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Nuclear Medicine Software Market Size by Country (2021–2026)
7.4 Europe Nuclear Medicine Software Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Software Market Size (2021–2032)
8.2 Asia-Pacific Nuclear Medicine Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Nuclear Medicine Software Market Size by Region (2021–2026)
8.4 Asia-Pacific Nuclear Medicine Software Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Nuclear Medicine Software Market Size (2021–2032)
9.2 Latin America Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Nuclear Medicine Software Market Size by Country (2021–2026)
9.4 Latin America Nuclear Medicine Software Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Software Market Size (2021–2032)
10.2 Middle East & Africa Nuclear Medicine Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Nuclear Medicine Software Market Size by Country (2021–2026)
10.4 Middle East & Africa Nuclear Medicine Software Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 iQ IMAGE
11.1.1 iQ IMAGE Company Details
11.1.2 iQ IMAGE Business Overview
11.1.3 iQ IMAGE Nuclear Medicine Software Introduction
11.1.4 iQ IMAGE Revenue in Nuclear Medicine Software Business (2021–2026)
11.1.5 iQ IMAGE Recent Development
11.2 Mediso
11.2.1 Mediso Company Details
11.2.2 Mediso Business Overview
11.2.3 Mediso Nuclear Medicine Software Introduction
11.2.4 Mediso Revenue in Nuclear Medicine Software Business (2021–2026)
11.2.5 Mediso Recent Development
11.3 Segami
11.3.1 Segami Company Details
11.3.2 Segami Business Overview
11.3.3 Segami Nuclear Medicine Software Introduction
11.3.4 Segami Revenue in Nuclear Medicine Software Business (2021–2026)
11.3.5 Segami Recent Development
11.4 Hermes Medical Solutions
11.4.1 Hermes Medical Solutions Company Details
11.4.2 Hermes Medical Solutions Business Overview
11.4.3 Hermes Medical Solutions Nuclear Medicine Software Introduction
11.4.4 Hermes Medical Solutions Revenue in Nuclear Medicine Software Business (2021–2026)
11.4.5 Hermes Medical Solutions Recent Development
11.5 MIM Software Inc
11.5.1 MIM Software Inc Company Details
11.5.2 MIM Software Inc Business Overview
11.5.3 MIM Software Inc Nuclear Medicine Software Introduction
11.5.4 MIM Software Inc Revenue in Nuclear Medicine Software Business (2021–2026)
11.5.5 MIM Software Inc Recent Development
11.6 LabLogic
11.6.1 LabLogic Company Details
11.6.2 LabLogic Business Overview
11.6.3 LabLogic Nuclear Medicine Software Introduction
11.6.4 LabLogic Revenue in Nuclear Medicine Software Business (2021–2026)
11.6.5 LabLogic Recent Development
11.7 scintido
11.7.1 scintido Company Details
11.7.2 scintido Business Overview
11.7.3 scintido Nuclear Medicine Software Introduction
11.7.4 scintido Revenue in Nuclear Medicine Software Business (2021–2026)
11.7.5 scintido Recent Development
11.8 Gamma Gurus
11.8.1 Gamma Gurus Company Details
11.8.2 Gamma Gurus Business Overview
11.8.3 Gamma Gurus Nuclear Medicine Software Introduction
11.8.4 Gamma Gurus Revenue in Nuclear Medicine Software Business (2021–2026)
11.8.5 Gamma Gurus Recent Development
11.9 Mirion Medical
11.9.1 Mirion Medical Company Details
11.9.2 Mirion Medical Business Overview
11.9.3 Mirion Medical Nuclear Medicine Software Introduction
11.9.4 Mirion Medical Revenue in Nuclear Medicine Software Business (2021–2026)
11.9.5 Mirion Medical Recent Development
11.10 PAIRE
11.10.1 PAIRE Company Details
11.10.2 PAIRE Business Overview
11.10.3 PAIRE Nuclear Medicine Software Introduction
11.10.4 PAIRE Revenue in Nuclear Medicine Software Business (2021–2026)
11.10.5 PAIRE Recent Development
11.11 GE HealthCare
11.11.1 GE HealthCare Company Details
11.11.2 GE HealthCare Business Overview
11.11.3 GE HealthCare Nuclear Medicine Software Introduction
11.11.4 GE HealthCare Revenue in Nuclear Medicine Software Business (2021–2026)
11.11.5 GE HealthCare Recent Development
11.12 Inter Medical
11.12.1 Inter Medical Company Details
11.12.2 Inter Medical Business Overview
11.12.3 Inter Medical Nuclear Medicine Software Introduction
11.12.4 Inter Medical Revenue in Nuclear Medicine Software Business (2021–2026)
11.12.5 Inter Medical Recent Development
11.13 Sirona
11.13.1 Sirona Company Details
11.13.2 Sirona Business Overview
11.13.3 Sirona Nuclear Medicine Software Introduction
11.13.4 Sirona Revenue in Nuclear Medicine Software Business (2021–2026)
11.13.5 Sirona Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Nuclear Medicine Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Drug Management
 Table 3. Key Players of Radiation Management
 Table 4. Key Players of Other
 Table 5. Global Nuclear Medicine Software Market Size Growth Rate by Deployment (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Key Players of On Premise Software
 Table 7. Key Players of Cloud-Based Software
 Table 8. Global Nuclear Medicine Software Market Size Growth Rate by Function (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Key Players of Image Acquisition and Reconstruction Software
 Table 10. Key Players of Image Processing and Analysis Software
 Table 11. Key Players of Reporting and Information Management Software
 Table 12. Key Players of Others
 Table 13. Global Nuclear Medicine Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 14. Global Nuclear Medicine Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 15. Global Nuclear Medicine Software Market Size by Region (US$ Million), 2021–2026
 Table 16. Global Nuclear Medicine Software Market Share by Region (2021–2026)
 Table 17. Global Nuclear Medicine Software Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 18. Global Nuclear Medicine Software Market Share by Region (2027–2032)
 Table 19. Nuclear Medicine Software Market Trends
 Table 20. Nuclear Medicine Software Market Drivers
 Table 21. Nuclear Medicine Software Market Challenges
 Table 22. Nuclear Medicine Software Market Restraints
 Table 23. Global Nuclear Medicine Software Revenue by Players (US$ Million), 2021–2026
 Table 24. Global Nuclear Medicine Software Market Share by Players (2021–2026)
 Table 25. Global Top Nuclear Medicine Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nuclear Medicine Software Revenue, 2025
 Table 26. Ranking of Global Top Nuclear Medicine Software Companies by Revenue (US$ Million) in 2025
 Table 27. Global 5 Largest Players Market Share by Nuclear Medicine Software Revenue (CR5 and HHI), 2021–2026
 Table 28. Global Key Players of Nuclear Medicine Software, Headquarters and Area Served
 Table 29. Global Key Players of Nuclear Medicine Software, Products and Applications
 Table 30. Global Key Players of Nuclear Medicine Software, Date of General Availability (GA)
 Table 31. Mergers and Acquisitions, Expansion Plans
 Table 32. Global Nuclear Medicine Software Market Size by Type (US$ Million), 2021–2026
 Table 33. Global Nuclear Medicine Software Revenue Market Share by Type (2021–2026)
 Table 34. Global Nuclear Medicine Software Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 35. Global Nuclear Medicine Software Revenue Market Share by Type (2027–2032)
 Table 36. Global Nuclear Medicine Software Market Size by Application (US$ Million), 2021–2026
 Table 37. Global Nuclear Medicine Software Revenue Market Share by Application (2021–2026)
 Table 38. Global Nuclear Medicine Software Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 39. Global Nuclear Medicine Software Revenue Market Share by Application (2027–2032)
 Table 40. North America Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. North America Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026
 Table 42. North America Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032
 Table 43. Europe Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Europe Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026
 Table 45. Europe Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032
 Table 46. Asia-Pacific Nuclear Medicine Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Asia-Pacific Nuclear Medicine Software Market Size by Region (US$ Million), 2021–2026
 Table 48. Asia-Pacific Nuclear Medicine Software Market Size by Region (US$ Million), 2027–2032
 Table 49. Latin America Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 50. Latin America Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026
 Table 51. Latin America Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032
 Table 52. Middle East & Africa Nuclear Medicine Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Middle East & Africa Nuclear Medicine Software Market Size by Country (US$ Million), 2021–2026
 Table 54. Middle East & Africa Nuclear Medicine Software Market Size by Country (US$ Million), 2027–2032
 Table 55. iQ IMAGE Company Details
 Table 56. iQ IMAGE Business Overview
 Table 57. iQ IMAGE Nuclear Medicine Software Product
 Table 58. iQ IMAGE Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 59. iQ IMAGE Recent Development
 Table 60. Mediso Company Details
 Table 61. Mediso Business Overview
 Table 62. Mediso Nuclear Medicine Software Product
 Table 63. Mediso Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 64. Mediso Recent Development
 Table 65. Segami Company Details
 Table 66. Segami Business Overview
 Table 67. Segami Nuclear Medicine Software Product
 Table 68. Segami Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 69. Segami Recent Development
 Table 70. Hermes Medical Solutions Company Details
 Table 71. Hermes Medical Solutions Business Overview
 Table 72. Hermes Medical Solutions Nuclear Medicine Software Product
 Table 73. Hermes Medical Solutions Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 74. Hermes Medical Solutions Recent Development
 Table 75. MIM Software Inc Company Details
 Table 76. MIM Software Inc Business Overview
 Table 77. MIM Software Inc Nuclear Medicine Software Product
 Table 78. MIM Software Inc Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 79. MIM Software Inc Recent Development
 Table 80. LabLogic Company Details
 Table 81. LabLogic Business Overview
 Table 82. LabLogic Nuclear Medicine Software Product
 Table 83. LabLogic Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 84. LabLogic Recent Development
 Table 85. scintido Company Details
 Table 86. scintido Business Overview
 Table 87. scintido Nuclear Medicine Software Product
 Table 88. scintido Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 89. scintido Recent Development
 Table 90. Gamma Gurus Company Details
 Table 91. Gamma Gurus Business Overview
 Table 92. Gamma Gurus Nuclear Medicine Software Product
 Table 93. Gamma Gurus Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 94. Gamma Gurus Recent Development
 Table 95. Mirion Medical Company Details
 Table 96. Mirion Medical Business Overview
 Table 97. Mirion Medical Nuclear Medicine Software Product
 Table 98. Mirion Medical Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 99. Mirion Medical Recent Development
 Table 100. PAIRE Company Details
 Table 101. PAIRE Business Overview
 Table 102. PAIRE Nuclear Medicine Software Product
 Table 103. PAIRE Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 104. PAIRE Recent Development
 Table 105. GE HealthCare Company Details
 Table 106. GE HealthCare Business Overview
 Table 107. GE HealthCare Nuclear Medicine Software Product
 Table 108. GE HealthCare Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 109. GE HealthCare Recent Development
 Table 110. Inter Medical Company Details
 Table 111. Inter Medical Business Overview
 Table 112. Inter Medical Nuclear Medicine Software Product
 Table 113. Inter Medical Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 114. Inter Medical Recent Development
 Table 115. Sirona Company Details
 Table 116. Sirona Business Overview
 Table 117. Sirona Nuclear Medicine Software Product
 Table 118. Sirona Revenue in Nuclear Medicine Software Business (US$ Million), 2021–2026
 Table 119. Sirona Recent Development
 Table 120. Research Programs/Design for This Report
 Table 121. Key Data Information from Secondary Sources
 Table 122. Key Data Information from Primary Sources
 Table 123. Authors List of This Report


List of Figures
 Figure 1. Nuclear Medicine Software Picture
 Figure 2. Global Nuclear Medicine Software Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Nuclear Medicine Software Market Share by Type: 2025 vs 2032
 Figure 4. Drug Management Features
 Figure 5. Radiation Management Features
 Figure 6. Other Features
 Figure 7. Global Nuclear Medicine Software Market Size Comparison by Deployment (US$ Million), 2021–2032
 Figure 8. On Premise Software Features
 Figure 9. Cloud-Based Software Features
 Figure 10. Global Nuclear Medicine Software Market Size Comparison by Function (US$ Million), 2021–2032
 Figure 11. Image Acquisition and Reconstruction Software Features
 Figure 12. Image Processing and Analysis Software Features
 Figure 13. Reporting and Information Management Software Features
 Figure 14. Others Features
 Figure 15. Global Nuclear Medicine Software Market Size by Application (US$ Million), 2021–2032
 Figure 16. Global Nuclear Medicine Software Market Share by Application: 2025 vs 2032
 Figure 17. Clinical Diagnosis Case Studies
 Figure 18. Research Case Studies
 Figure 19. Others Case Studies
 Figure 20. Nuclear Medicine Software Report Years Considered
 Figure 21. Global Nuclear Medicine Software Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 22. Global Nuclear Medicine Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Nuclear Medicine Software Market Share by Region: 2025 vs 2032
 Figure 24. Global Nuclear Medicine Software Market Share by Players in 2025
 Figure 25. Global Nuclear Medicine Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 26. The Top 10 and 5 Players Market Share by Nuclear Medicine Software Revenue in 2025
 Figure 27. North America Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. North America Nuclear Medicine Software Market Share by Country (2021–2032)
 Figure 29. United States Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Canada Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Europe Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Europe Nuclear Medicine Software Market Share by Country (2021–2032)
 Figure 33. Germany Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. France Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. U.K. Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Italy Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Russia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Ireland Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Asia-Pacific Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Asia-Pacific Nuclear Medicine Software Market Share by Region (2021–2032)
 Figure 41. China Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Japan Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. South Korea Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Southeast Asia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. India Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Australia & New Zealand Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Latin America Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Latin America Nuclear Medicine Software Market Share by Country (2021–2032)
 Figure 49. Mexico Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Brazil Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Middle East & Africa Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Middle East & Africa Nuclear Medicine Software Market Share by Country (2021–2032)
 Figure 53. Israel Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. UAE Nuclear Medicine Software Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. iQ IMAGE Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 57. Mediso Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 58. Segami Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 59. Hermes Medical Solutions Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 60. MIM Software Inc Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 61. LabLogic Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 62. scintido Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 63. Gamma Gurus Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 64. Mirion Medical Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 65. PAIRE Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 66. GE HealthCare Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 67. Inter Medical Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 68. Sirona Revenue Growth Rate in Nuclear Medicine Software Business (2021–2026)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS